Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2024

Open Access 13-12-2023 | Gastritis | Original Article

Prevalence of Histological Gastritis in a Community Population and Association with Epigastric Pain

Authors: Rachael Zuzek, Michael Potter, Nicholas J. Talley, L. Agréus, A. Andreasson, L. Veits, M. Vieth, M. M. Walker

Published in: Digestive Diseases and Sciences | Issue 2/2024

Login to get access

Abstract

Background and Aims

Gastritis is a common histological diagnosis, although the prevalence is decreasing in developed populations, alongside decreasing prevalence of H. pylori infection. We sought to determine the prevalence of the etiology of gastritis in a Swedish population sample and to analyze any associations with symptoms, an area of clinical uncertainty.

Methods

Longitudinal population-based study based in Östhammar, Sweden. A randomly sampled adult population completed a validated gastrointestinal symptom questionnaire (Abdominal Symptom Questionnaire, ASQ) in 2011 (N = 1175). Participants < 80 years of age and who were eligible were invited to undergo esophagogastroduodenoscopy (EGD) (N = 947); 402 accepted and 368 underwent EGD with antral and body biopsies (average 54.1 years, range 20–79 years; 47.8% male) with H. pylori serology.

Results

Gastritis was found in 40.2% (148/368; 95% CI 35.2–45.2%). By rank, the most common histological subtype was reactive (68/148; 45.9%), then H. pylori (44/148; 29.7%), chronic non-H. pylori (29/148; 19.6%), and autoimmune (4/148; 2.7%). Gastritis was significantly associated with older age and H. pylori status (p < 0.01). Gastritis subjects were divided into three histological categories: chronic inactive inflammation, autoimmune gastritis, and active inflammation; there was no difference in the presence of upper gastrointestinal symptoms when categories were compared to cases with no pathological changes. Functional dyspepsia or gastroesophageal reflux were reported in 25.7% (38/148) of those with gastritis (any type or location) versus 34.1% (75/220) with no pathological changes (p = 0.32). Epigastric pain was more common in chronic H. pylori negative gastritis in the gastric body (OR = 3.22, 95% CI 1.08–9.62).

Conclusion

Gastritis is common in the population with a prevalence of 40% and is usually asymptomatic. Chronic body gastritis may be associated with epigastric pain, but independent validation is required to confirm these findings. Clinicians should not generally ascribe symptoms to histological gastritis.
Literature
1.
go back to reference Odze R, Goldblum J. Inflammatory disorders of the stomach. In: 2nd edn. Philadelphia: Saunders; 2009; 285. Odze R, Goldblum J. Inflammatory disorders of the stomach. In: 2nd edn. Philadelphia: Saunders; 2009; 285.
3.
go back to reference Agréus L, Hellström PM, Talley NJ, Wallner B, Forsberg A, Vieth M et al. Towards a healthy stomach? Helicobacter pylori prevalence has dramatically decreased over 23 years in adults in a Swedish community. United Eur Gastroenterol J. 2016;4:686–696.CrossRef Agréus L, Hellström PM, Talley NJ, Wallner B, Forsberg A, Vieth M et al. Towards a healthy stomach? Helicobacter pylori prevalence has dramatically decreased over 23 years in adults in a Swedish community. United Eur Gastroenterol J. 2016;4:686–696.CrossRef
4.
go back to reference Kumagai T, Malaty HM, Graham DY, Hosogaya S, Misawa K, Furihata K et al. Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study. J Infect Dis. 1998;178:717–721.CrossRefPubMed Kumagai T, Malaty HM, Graham DY, Hosogaya S, Misawa K, Furihata K et al. Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study. J Infect Dis. 1998;178:717–721.CrossRefPubMed
5.
go back to reference Ciociola AA, McSorley DJ, Turner K, Sykes D, Palmer JBD. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol. 1999;94:1834–1840.CrossRefPubMed Ciociola AA, McSorley DJ, Turner K, Sykes D, Palmer JBD. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol. 1999;94:1834–1840.CrossRefPubMed
6.
go back to reference Asfeldt AM, Steigen SE, Løchen ML, Straume B, Johnsen R, Bernersen B et al. The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: the Sørreisa gastrointestinal disorder study. Eur J Epidemiol. 2009;24:649–658.CrossRefPubMed Asfeldt AM, Steigen SE, Løchen ML, Straume B, Johnsen R, Bernersen B et al. The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: the Sørreisa gastrointestinal disorder study. Eur J Epidemiol. 2009;24:649–658.CrossRefPubMed
7.
go back to reference Wolf EM, Plieschnegger W, Geppert M, Wigginghaus B, Höss GM, Eherer A et al. Changing prevalence patterns in endoscopic and histological diagnosis of gastritis? Data from a cross-sectional Central European multicentre study. Dig Liver Dis. 2014;46:412–418.CrossRefPubMed Wolf EM, Plieschnegger W, Geppert M, Wigginghaus B, Höss GM, Eherer A et al. Changing prevalence patterns in endoscopic and histological diagnosis of gastritis? Data from a cross-sectional Central European multicentre study. Dig Liver Dis. 2014;46:412–418.CrossRefPubMed
8.
go back to reference Nordenstedt H, Graham DY, Kramer JR, Rugge M, Verstovsek G, Fitzgerald S et al. Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol. 2013;108:65–71.CrossRefPubMed Nordenstedt H, Graham DY, Kramer JR, Rugge M, Verstovsek G, Fitzgerald S et al. Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol. 2013;108:65–71.CrossRefPubMed
9.
go back to reference Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 1989;321:1562–1566.CrossRefPubMed Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 1989;321:1562–1566.CrossRefPubMed
11.
go back to reference Veldhuyzen Van Zanten S. The role of Helicobacter pylori infection in non-ulcer dyspepsia. Aliment Pharmacol Ther. 1997;11:63–9.CrossRefPubMed Veldhuyzen Van Zanten S. The role of Helicobacter pylori infection in non-ulcer dyspepsia. Aliment Pharmacol Ther. 1997;11:63–9.CrossRefPubMed
12.
go back to reference Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992;102:1259–1268.CrossRefPubMed Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992;102:1259–1268.CrossRefPubMed
13.
go back to reference Tytgat GNJ. Role of endoscopy and biopsy in the work up of dyspepsia. Gut. 2002;50:13–16. Tytgat GNJ. Role of endoscopy and biopsy in the work up of dyspepsia. Gut. 2002;50:13–16.
14.
go back to reference Borch K, Jõnsson KÅ, Petersson F, Redéen S, Mårdh S, Franzén LE. Prevalence of gastroduodenitis and Helicobacter priori infection in a general population sample: relations to symptomatology and life-style. Dig Dis Sci. 2000;45:1322–1329.CrossRefPubMed Borch K, Jõnsson KÅ, Petersson F, Redéen S, Mårdh S, Franzén LE. Prevalence of gastroduodenitis and Helicobacter priori infection in a general population sample: relations to symptomatology and life-style. Dig Dis Sci. 2000;45:1322–1329.CrossRefPubMed
15.
go back to reference Johnsen R, Bernersen B, Straume B, Forde OH, Bostad L, Burhol PG. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. Br Med J. 1991;302:749–752.CrossRef Johnsen R, Bernersen B, Straume B, Forde OH, Bostad L, Burhol PG. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. Br Med J. 1991;302:749–752.CrossRef
16.
go back to reference Agréus L, Engstrand L, Svärdsudd K, Nyrén O, Tibblin G. Helicobacter pylori seropositivity among Swedish adults with and without abdominal symptoms: a population-based epidemiologic study. Scand J Gastroenterol. 1995;30:752–757.CrossRefPubMed Agréus L, Engstrand L, Svärdsudd K, Nyrén O, Tibblin G. Helicobacter pylori seropositivity among Swedish adults with and without abdominal symptoms: a population-based epidemiologic study. Scand J Gastroenterol. 1995;30:752–757.CrossRefPubMed
17.
go back to reference Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995;109:671–680.CrossRefPubMed Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995;109:671–680.CrossRefPubMed
18.
go back to reference Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol. 2001;96:2905–2914.CrossRefPubMed Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol. 2001;96:2905–2914.CrossRefPubMed
19.
go back to reference Agreus L, Svärdsudd K, Nyrén O, Tibblin G. Reproducibility and validity of a postal questionnaire: the abdominal symptom study. Scand J Prim Health Care. 1993;11:252–262.CrossRefPubMed Agreus L, Svärdsudd K, Nyrén O, Tibblin G. Reproducibility and validity of a postal questionnaire: the abdominal symptom study. Scand J Prim Health Care. 1993;11:252–262.CrossRefPubMed
20.
go back to reference Vakil N, Van Zanten SV, Kahrilas P, Dent J, Jones R. The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus CME. Am J Gastroenterol. 2006;101:1900–1920.CrossRefPubMed Vakil N, Van Zanten SV, Kahrilas P, Dent J, Jones R. The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus CME. Am J Gastroenterol. 2006;101:1900–1920.CrossRefPubMed
21.
go back to reference Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ. Gastroduodenal disorders. Gastroenterology. 2016;150:1380–1392.CrossRefPubMed Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ. Gastroduodenal disorders. Gastroenterology. 2016;150:1380–1392.CrossRefPubMed
22.
go back to reference Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.CrossRefPubMed Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.CrossRefPubMed
23.
go back to reference Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis-pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10:529–41.CrossRefPubMed Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis-pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10:529–41.CrossRefPubMed
24.
go back to reference Sonnenberg A, Genta RM. Changes in the gastric mucosa with aging. Clin Gastroenterol Hepatol. 2015;13:2276–2281.CrossRefPubMed Sonnenberg A, Genta RM. Changes in the gastric mucosa with aging. Clin Gastroenterol Hepatol. 2015;13:2276–2281.CrossRefPubMed
25.
go back to reference Muszyński J, Ziółkowski B, Kotarski P, Niegowski A, Górnicka B, Bogdańska M et al. Gastritis—facts and doubts. Prz Gastroenterol. 2016;11:286–295.PubMedPubMedCentral Muszyński J, Ziółkowski B, Kotarski P, Niegowski A, Górnicka B, Bogdańska M et al. Gastritis—facts and doubts. Prz Gastroenterol. 2016;11:286–295.PubMedPubMedCentral
26.
go back to reference Wolf EM, Plieschnegger W, Schmack B, Bordel H, Höfler B, Eherer A et al. Evolving patterns in the diagnosis of reactive gastropathy: data from a prospective Central European multicenter study with proposal of a new histologic scoring system. Pathol Res Pract. 2014;210:847–854.CrossRefPubMed Wolf EM, Plieschnegger W, Schmack B, Bordel H, Höfler B, Eherer A et al. Evolving patterns in the diagnosis of reactive gastropathy: data from a prospective Central European multicenter study with proposal of a new histologic scoring system. Pathol Res Pract. 2014;210:847–854.CrossRefPubMed
27.
go back to reference Lopes AI, Vale FF, Oleastro M. Helicobacter pylori infection—recent developments in diagnosis. World J Gastroenterol. 2014;20:9299–9313.PubMedPubMedCentral Lopes AI, Vale FF, Oleastro M. Helicobacter pylori infection—recent developments in diagnosis. World J Gastroenterol. 2014;20:9299–9313.PubMedPubMedCentral
28.
go back to reference Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K et al. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: a report on histology and H. pylori detection in the general adult population. Scand J Gastroenterol. 2005;40:302–11.CrossRefPubMed Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K et al. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: a report on histology and H. pylori detection in the general adult population. Scand J Gastroenterol. 2005;40:302–11.CrossRefPubMed
29.
go back to reference Ibrahim A, Morais S, Ferro A, Lunet N, Peleteiro B. Sex-differences in the prevalence of Helicobacter pylori infection in pediatric and adult populations: systematic review and meta-analysis of 244 studies. Dig Liver Dis. 2017;49:742–749.CrossRefPubMed Ibrahim A, Morais S, Ferro A, Lunet N, Peleteiro B. Sex-differences in the prevalence of Helicobacter pylori infection in pediatric and adult populations: systematic review and meta-analysis of 244 studies. Dig Liver Dis. 2017;49:742–749.CrossRefPubMed
30.
go back to reference Nasser SC, Slim M, Nassif JG, Nasser SM. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes. World J Gastroenterol. 2015;21:4599–4606.CrossRefPubMedPubMedCentral Nasser SC, Slim M, Nassif JG, Nasser SM. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes. World J Gastroenterol. 2015;21:4599–4606.CrossRefPubMedPubMedCentral
31.
go back to reference Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology. 1995;108:917–924.CrossRefPubMed Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology. 1995;108:917–924.CrossRefPubMed
32.
go back to reference Katelaris P, Hunt R, Bazzoli F, Cohen H, Fock KM, Gemilyan M, Malfertheiner P, Mégraud F, Piscoya A, Quach D, Vakil N, Vaz Coelho LG, LeMair A, Melberg J. Helicobacter pylori world gastroenterology organization global guideline. J Clin Gastroenterol. 2023;57:111–126.CrossRefPubMed Katelaris P, Hunt R, Bazzoli F, Cohen H, Fock KM, Gemilyan M, Malfertheiner P, Mégraud F, Piscoya A, Quach D, Vakil N, Vaz Coelho LG, LeMair A, Melberg J. Helicobacter pylori world gastroenterology organization global guideline. J Clin Gastroenterol. 2023;57:111–126.CrossRefPubMed
33.
go back to reference Aro P, Storskrubb T, Ronkainen J, Bolling-Sternevald E, Engstrand L, Vieth M et al. Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol. 2006;163:1025–1034.CrossRefPubMed Aro P, Storskrubb T, Ronkainen J, Bolling-Sternevald E, Engstrand L, Vieth M et al. Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol. 2006;163:1025–1034.CrossRefPubMed
34.
go back to reference Lan L, Yu J, Chen YL, Zhong YL, Zhang H, Jia CH et al. Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia. World J Gastroenterol. 2011;17:3242–3247.PubMedPubMedCentral Lan L, Yu J, Chen YL, Zhong YL, Zhang H, Jia CH et al. Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia. World J Gastroenterol. 2011;17:3242–3247.PubMedPubMedCentral
35.
go back to reference Mera R, Fontham ETH, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut. 2005;54:1536–1540.CrossRefPubMedPubMedCentral Mera R, Fontham ETH, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut. 2005;54:1536–1540.CrossRefPubMedPubMedCentral
36.
go back to reference Ford A, Mahadeva S, Carbone F, Lacy BE, Talley NJ. Functional dyspepsia. The Lancet 2020;396:1689–1702.CrossRef Ford A, Mahadeva S, Carbone F, Lacy BE, Talley NJ. Functional dyspepsia. The Lancet 2020;396:1689–1702.CrossRef
37.
go back to reference Carabotti M, Lahner E, Esposito G, Sacchi MC, Severi C, Annibale B. Upper gastrointestinal symptoms in autoimmune gastritis a cross-sectional study. Med (United States). 2017;96:15784. Carabotti M, Lahner E, Esposito G, Sacchi MC, Severi C, Annibale B. Upper gastrointestinal symptoms in autoimmune gastritis a cross-sectional study. Med (United States). 2017;96:15784.
38.
go back to reference Talley NJ, Walker MM, Aro P, Ronkainen J, Storskrubb T, Hindley LA et al. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol. 2007;5:1175–1183.CrossRefPubMed Talley NJ, Walker MM, Aro P, Ronkainen J, Storskrubb T, Hindley LA et al. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol. 2007;5:1175–1183.CrossRefPubMed
39.
go back to reference Shah A, Fairlie T, Brown G, Jones MP, Eslick GD, Duncanson K, Thapar N, Keely S, Koloski N, Shahi M, Walker MM, Talley NJ, Holtmann G. Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studies. Clin Gastroenterol Hepatol. 2022;20:2229–2242.e29.CrossRefPubMed Shah A, Fairlie T, Brown G, Jones MP, Eslick GD, Duncanson K, Thapar N, Keely S, Koloski N, Shahi M, Walker MM, Talley NJ, Holtmann G. Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studies. Clin Gastroenterol Hepatol. 2022;20:2229–2242.e29.CrossRefPubMed
Metadata
Title
Prevalence of Histological Gastritis in a Community Population and Association with Epigastric Pain
Authors
Rachael Zuzek
Michael Potter
Nicholas J. Talley
L. Agréus
A. Andreasson
L. Veits
M. Vieth
M. M. Walker
Publication date
13-12-2023
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08170-2

Other articles of this Issue 2/2024

Digestive Diseases and Sciences 2/2024 Go to the issue

Profiles and Perspectives

DDS Profile: Evan S. Dellon, MD, MPH

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.